Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China flag China · Delayed Price · Currency is CNY
51.28
-1.53 (-2.90%)
At close: Mar 9, 2026
33.09%
Market Cap 1.99B
Revenue (ttm) 162.06M
Net Income (ttm) 9.51M
Shares Out 38.78M
EPS (ttm) 0.24
PE Ratio 213.67
Forward PE n/a
Dividend 0.30 (0.59%)
Ex-Dividend Date Nov 26, 2025
Volume 510,007
Average Volume 495,138
Open 51.82
Previous Close 52.81
Day's Range 50.02 - 52.32
52-Week Range 30.60 - 60.60
Beta 0.31
RSI 46.68
Earnings Date Apr 29, 2026

About SHA:688193

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 290
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688193
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.